Anti-erbB-2 (Her-2/neu) (4D5-8 (trastuzumab))

Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)], Recombinant, IgG1 kappa, Human
SKU
ABAAb00103-10.17
Packaging Unit
200 μg
Manufacturer
Absolute Antibody

Availability: loading...
Price is loading...
CloneID: 4D5-8 (trastuzumab)

Antigen Long Description: A431 cells (human epidermoid carcinoma) (over)expressing EGFR.

Buffer Composition: PBS with 0.02% Proclin 300.

Available Custom Conjugation Options: AP, HRP, Fluorescein, APC, PE, Biotin Type A, Biotin Type B, Streptavidin, FluoroProbes 647H, Atto488, APC/Cy7, PE/Cy7

Uniprot Accession No.: P04626

Specificity Statement: Oncogenic protein Her-2/neu (erbB-2), a member of the family of epidermal growth factor (EGF) receptors, overexpressed in 30% of invasive breast cancers and 70% of ductal carcinomata in situ, in a small percentage of melanomas, and in other malignancies originating from various organs, including ovary, kidney, colon, and bladder.

Application Notes (Clone): This antibody binds to erbB-2/Her-2/neu has therapeutic indications particularly in the treatment of breast cancer (c.f. Herceptin). It can also be used to detect HER-2 by flow cytometry or IHC (Glazyrin 2007).
More Information
SKU ABAAb00103-10.17
Manufacturer Absolute Antibody
Manufacturer SKU Ab00103-10.17
Package Unit 200 μg
Quantity Unit STK
Reactivity Human
Clonality Recombinant
Application ELISA, Flow Cytometry, Immunohistochemistry
Isotype IgG1 kappa
Host Human
Product information (PDF) Download
MSDS (PDF) Download